. Serum 25(OH)D levels at baseline and anthropometric measures at both baseline and follow-up were available in a random sample of 2,460 subjects. Overall, 40% of the 2,460 subjects had a serum 25(OH)D level <50.0 nmol/L, and 37% had a level of 50.0-74.9 nmol/L. The prevalence and cumulative incidence of obesity defined by body mass index (BMI) ≥30 kg/m 2 was 12% and 15%. Lower serum 25(OH)D level was associated with higher prevalence of obesity. In the 2,165 subjects with baseline BMI <30 kg/m 2 , serum
Both obesity and vitamin D insufficiency are highly prevalent world wide (1) (2) (3) . They are associated with each other (4) (5) (6) , but the nature of the association requires clarification.
Obesity has been proposed to lead to low body vitamin D status, although this directional association has been investigated in very few prospective epidemiologic studies (5) . Due to its hydrophobic characteristics, vitamin D may move out of the circulation into the large amount of adipose tissue in obese subjects, resulting in low serum levels of 25-hydroxyvitamin D [25(OH)D] even if the total body storage of vitamin D might be adequate (7) . There is also a possibility that low vitamin D status increases the risk of obesity (8), since vitamin D appears to modulate the catabolic and anabolic activity of adipocytes in experimental studies (9) . A recent study of Colombian children demonstrated that low serum 25(OH)D level was associated with a significant increase in adiposity, measured by changes in body mass index (BMI), skin-fold thickness and waist circumference (WC) during a follow-up period of approximately 3 years (10) . By contrast, another prospective epidemiologic study from the United States did not observe any significant associations of 25(OH)D with changes in BMI and adipose tissue values in Hispanic and African American adults after a 5-year follow-up (11) . In the present study, we used data from the Nord-Trøndelag Health Study in Norway to investigate the cross-sectional and prospective associations of serum 25(OH)D level and obesity in adults, who were followed up for 11 years on average.
MATERIALS AND METHODS

Study population
The Nord-Trøndelag Health Study (HUNT) is the largest and most comprehensive population health survey in Norway. The adult part of the HUNT invited all inhabitants aged 19 years or older in the county of Nord-Trøndelag in the three separate surveys: HUNT 1 (1984-86) , HUNT 2 (1995-97) and HUNT 3 (2006-08) (12) . Briefly, HUNT 2 invited about 93,000 adults in 1995-97, and 65,215 subjects participated (response rate: 70%). Among them, 57%
(n = 37,059) took part in HUNT 3 in 2006-08 (Figure 1 ). We established a cohort that included all subjects who participated in both HUNT 2 and HUNT 3 and were aged <65 years in HUNT 3 (n = 25,616). This cohort was initially designed to study incident asthma. The age limit was set to decrease misclassification of asthma and chronic obstructive pulmonary disease.
Serum 25(OH)D level
Blood samples were collected from the HUNT 2 participants and stored at -20°C freezers for later use. A 10% random sample of the cohort participants was selected for baseline serum 25(OH)D measurements (n = 2,584) and, of these, 2,505 subjects had sufficient volume of serum. Baseline serum 25(OH)D levels were measured by using LIAISON ® 25-OH Vitamin D TOTAL (DiaSorin, Saluggia, Italy), a fully automated antibody-based chemiluminescence assay. The detection range of the assay is 10 to 375 nmol/L. The assay has an intra-assay coefficient of variation of 4% and an inter-assay coefficient of variation of 8%.
Exposure variable and covariates 6 Baseline serum 25(OH)D levels were classified into three groups: <50.0, 50.0-74.9 and ≥75.0 nmol/L. These are widely used cut-off points in scientific literature (13) (14) (15) . Other important variables at baseline such as age, smoking habits, education, physical activity, and socioeconomic status were collected in HUNT 2. These covariates were categorized as: age (19-29, 30-39, 40-49 , and 50-55 years), daily smoker (yes/no), years of education (<10, 10-12, and ≥13 years), average hours of light physical activity per week (<1, 1-2, and ≥3 hours), social benefit recipient (yes/no), and economic difficulties (yes/no). Social benefit recipients were those who reported receiving any of the public welfare benefits, such as sick pay/rehabilitation/retraining/unemployment/transitional benefits, disability/retirement/widow's pension, family income supplement, and/or other benefits.
Subjects who had economic difficulties were identified by their affirmative answer to the question, "During the last year, has it at any time been difficult to meet the costs of food, transportation, housing and such?" People with missing information of smoking, education, physical activity, and socioeconomic status were grouped into an "unknown" category for each variable and included in analyses.
Outcome variables
Body weight, height, and WC were measured by health professionals in both HUNT 2 and 
Ethics
The study was approved by the Regional Committee for Medical Research Ethics. All participants gave their informed written consent. Table 1 shows the baseline characteristics in the 2,460 random sample and the rest of the cohort population (n = 23,156). There were no significant differences in baseline characteristics between the two groups (for all P > 0.05).
RESULTS
The prevalence of BMI-defined obesity was 12% at baseline in the random sample, and the cumulative incidence of obesity during the 11-year follow-up period was 15% in the 2,165 subjects without baseline obesity. Older age and difficult economic situation were significantly associated with an increased OR for prevalent obesity at baseline ( Table 2) , Table 3) . A similar trend was observed for cumulative incidence of obesity in the 2,165 subjects without obesity at baseline. When obesity was defined by WC (≥88 cm for women; ≥102 cm for men) the prevalence of obesity was 14% in the random sample, and the cumulative incidence of obesity at 11-year follow-up period was 38% in the 2,114 subjects without baseline obesity (by WC criteria).
The associations of baseline serum 25(OH)D level with prevalent and incident obesity defined by WC were similar to those for obesity defined by BMI . In the multivariable logistic regression model, serum 25(OH)D level <50.0 nmol/L was significantly associated with 2.6-time increased odds for prevalent obesity and 1.6-time increased odds for incident obesity (Table 4) (27, 28) . In addition, a previous study provided some evidence for a small variation of 25(OH)D levels overtime in adults after taking season into consideration (27) .
Body weight, height and waist circumference were objectively measured and obesity was classified by standard definitions. The prevalence of obesity in present study was in line with that of in the general population in Norway (29).
Although the independent association between serum 25(OH)D level and incident obesity remained after adjustment for several important covariates, there is a possibility of additional confounding. For example, the measurement of some covariates, such as physical activity, is not perfect and we also lacked data on energy intake and dietary intake in general. Socioeconomic status can be used as a proxy measure for dietary factors since low social status is associated with diet insecurity (30) . Our study demonstrated that the association of 25(OH)D with obesity development was independent of low socio-economic status. This confounding, if existed, would need to be quite large, however, to explain the observed ORs. Furthermore, our finding may have limited generalizability to the entire adult population due to the age limit at enrollment. Studies on association between vitamin D and obesity development in elderly people are called for.
To summarize, obesity is widely-recognized to lead to lower vitamin D status in the body due to the fat soluble property of vitamin D and other factors (7). This inference was mainly made from cross-sectional associations (4-6) and a few prospective observations and clinical trials (5, 31, 32) . Our study confirmed the cross-sectional association, but also provided new evidence that lower 25(OH)D levels may contribute to new-onset obesity in adults. We also found that central obesity increased more rapidly than overall obesity (38% vs. 15%) and lower serum 25(OH)D level was a risk factor for both overall and central obesity. The detrimental effects of overall obesity have been shown world-wide (33) (34) (35) . Central obesity is an important component and a risk factor of metabolic syndrome (36) . Recent research has also provided evidence for the multiple adverse effects of central abdominal obesity (37) (38) (39) .
Thus, the implication can be profound if improvement of vitamin D status could reduce both overall and central obesity. We suggest that there might be a harmful cycle (i.e., low vitamin D  obesity  low vitamin D) that complicates obesity prevention and treatment efforts.
This possibility merits further research in well-designed large prospective studies. 
